|
Delayed
Nasdaq Stockholm
03:24:19 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 1.826 SEK | +1.22% |
|
-0.76% | -7.31% |
| 09-03 | Irlab CEO Kristina Torfgaard to step down in 2027 | FW |
| 09-03 | Irlab CEO Kristina Torfgaard wants to step down | FW |
EPS & Dividend: IRLAB Therapeutics AB
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.922 | 1 | -2.188 | -3.429 | -1.603 | -1.642 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 42.000 | 44.000 | 38.300 | 7.500 | 10.750 | 1.970 |
| Nbr of stocks (in thousands) | 51,748 | 51,748 | 51,868 | 51,868 | 51,868 | 84,938 |
| Announcement Date | 4/15/21 | 4/8/22 | 4/29/24 | 4/29/24 | 4/25/25 | 4/29/26 |
1SEK in Million2SEK
Estimates
Past dividends: IRLAB Therapeutics AB
| 2026-06-08 | Ex-dividend date - 0.97854 SEK | 00:00 |
Upcoming Events: IRLAB Therapeutics AB
| 2026-11-13 | Earnings release | Q3 2026 | |
| 2027-02-24 | Earnings release | Annual 2026 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.61% | 0.68% | 32.46x | 20.64x | 11.79x | |
| 2.11% | 2.2% | 28.13x | 7.06x | 6.24x | |
| 2.61% | 2.71% | 33.64x | -483.97x | 7.86x | |
| 2.45% | 2.55% | 101.52x | 7.1x | 5.7x | |
| 2.87% | 2.94% | 18.95x | 6.93x | 4.61x | |
| 3.1% | 3.23% | 19.74x | 5.62x | 5.16x | |
| 2.15% | 2.28% | 19.84x | 4.46x | 4.13x | |
| 2.5% | 2.64% | 25.45x | 19.25x | 6.66x | |
| 2.28% | 2.32% | -43.74x | 10.77x | 6.39x | |
| Average | 2.3% | 2.39% | 26.22x | -44.68x | 6.50x | |
| Weighted average by Cap. | 1.96% | 2.05% | 31.25x | -51.18x | 7.60x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
